Literature DB >> 24972973

Controversies in management of achalasia.

Marco G Patti1, Piero M Fisichella.   

Abstract

BACKGROUND: Esophageal achalasia is a primary motility disorder of unknown etiology. It is characterized by lack of esophageal peristalsis and failure of the lower esophageal sphincter to relax appropriately in response to swallowing. The goal of treatment is to improve esophageal emptying and patient's symptoms by decreasing the functional obstruction at the level of the gastroesophageal junction. This can be accomplished by either endoscopic modalities (intra-sphincteric injection of botulinum toxin, pneumatic dilatation, per oral endoscopic myotomy) or by a laparoscopic Heller myotomy.
RESULTS: Review of the current literature suggests that a laparoscopic Heller myotomy should be considered today the primary form of treatment for achalasia and recommends a treatment algorithm for this disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24972973     DOI: 10.1007/s11605-014-2556-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  32 in total

1.  Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia.

Authors:  M G Patti; C V Feo; M Arcerito; M De Pinto; A Tamburini; U Diener; W Gantert; L W Way
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

2.  Peroral endoscopic myotomy (POEM) for esophageal achalasia.

Authors:  H Inoue; H Minami; Y Kobayashi; Y Sato; M Kaga; M Suzuki; H Satodate; N Odaka; H Itoh; S Kudo
Journal:  Endoscopy       Date:  2010-03-30       Impact factor: 10.093

3.  Peroral endoscopic myotomy for the treatment of achalasia: an international prospective multicenter study.

Authors:  Daniel Von Renteln; Karl-Hermann Fuchs; Paul Fockens; Peter Bauerfeind; Melina C Vassiliou; Yuki B Werner; Gerald Fried; Wolfram Breithaupt; Henriette Heinrich; Albert J Bredenoord; Jan F Kersten; Tessa Verlaan; Michael Trevisonno; Thomas Rösch
Journal:  Gastroenterology       Date:  2013-05-09       Impact factor: 22.682

Review 4.  Fundoplication after laparoscopic Heller myotomy for esophageal achalasia: what type?

Authors:  Marco G Patti; Fernando A Herbella
Journal:  J Gastrointest Surg       Date:  2010-03-19       Impact factor: 3.452

5.  The outcome of laparoscopic Heller myotomy for achalasia is not influenced by the degree of esophageal dilatation.

Authors:  Matthew P Sweet; Ian Nipomnick; Warren J Gasper; Karen Bagatelos; James W Ostroff; Piero M Fisichella; Lawrence W Way; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2007-08-21       Impact factor: 3.452

6.  Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experience.

Authors:  Giovanni Zaninotto; Mario Costantini; Christian Rizzetto; Lisa Zanatta; Emanuela Guirroli; Giuseppe Portale; Loredana Nicoletti; Francesco Cavallin; Giorgio Battaglia; Alberto Ruol; Ermanno Ancona
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

7.  Clinical, radiological, and manometric profile in 145 patients with untreated achalasia.

Authors:  Piero M Fisichella; Dan Raz; Francesco Palazzo; Ian Niponmick; Marco G Patti
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

8.  Long-term outcomes of an endoscopic myotomy for achalasia: the POEM procedure.

Authors:  Lee L Swanstrom; Ashwin Kurian; Christy M Dunst; Ahmed Sharata; Neil Bhayani; Erwin Rieder
Journal:  Ann Surg       Date:  2012-10       Impact factor: 12.969

9.  Excellent outcomes of laparoscopic esophagomyotomy for achalasia in patients older than 60 years of age.

Authors:  Garrett R Roll; Sandi Ma; Warren J Gasper; Marco Patti; Lawrence W Way; Jonathan Carter
Journal:  Surg Endosc       Date:  2010-04-02       Impact factor: 4.584

10.  Long-term outcomes confirm the superior efficacy of extended Heller myotomy with Toupet fundoplication for achalasia.

Authors:  A S Wright; C W Williams; C A Pellegrini; B K Oelschlager
Journal:  Surg Endosc       Date:  2007-03-01       Impact factor: 3.453

View more
  3 in total

1.  Gastrointestinal Uses of Botulinum Toxin.

Authors:  Maria Cariati; Maria Michela Chiarello; Marco Cannistra'; Maria Antonietta Lerose; Giuseppe Brisinda
Journal:  Handb Exp Pharmacol       Date:  2021

Review 2.  Treatment of gastrointestinal sphincters spasms with botulinum toxin A.

Authors:  Giuseppe Brisinda; Nicola Sivestrini; Giuseppe Bianco; Giorgio Maria
Journal:  Toxins (Basel)       Date:  2015-05-29       Impact factor: 4.546

Review 3.  Management of achalasia in the UK, do we need new guidelines?

Authors:  Jihene El Kafsi; Antonio Foliaki; Thomas C B Dehn; Nicholas D Maynard
Journal:  Ann Med Surg (Lond)       Date:  2016-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.